LifeMD, Inc.
LFMDNASDAQHealthcare● Active
$5.02
+$0.13(+2.66%)
Market Cap$242779750
P/E Ratio—
52W High$15.84
52W Low$2.56
LifeMD, Inc. (LFMD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
LFMD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
-$0.20
Est. -$0.14 · -42.9%
Revenue
$0.05B
Est. $0.05B · +2.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
LFMD reports quarterly as a NASDAQ-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | -$0.15 | — | — | — | $0.05B | — |
| ▼ Q2 FY2026 | May 6, 2026 | -$0.14 | -$0.20 | -42.9% | $0.05B | $0.05B | +2.7% |
| ▼ Q1 FY2026 | Mar 9, 2026 | -$0.01 | -$0.04 | -300.0% | $0.05B | $0.05B | +2.3% |
| ▼ Q4 FY2025 | Nov 17, 2025 | -$0.06 | -$0.10 | -66.7% | $0.06B | $0.05B | +23.9% |
| ▼ Q3 FY2025 | Aug 4, 2025 | $0.18 | -$0.05 | -126.0% | $0.06B | $0.07B | -6.2% |
| ▲ Q2 FY2025 | May 6, 2025 | -$0.04 | $0.01 | +125.0% | $0.07B | $0.07B | +0.4% |
| ▲ Q1 FY2025 | Mar 10, 2025 | -$0.04 | -$0.02 | +50.0% | $0.06B | $0.06B | +7.8% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.12 | -$0.14 | -16.7% | $0.05B | $0.06B | -7.7% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
-$0.15
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
-$0.20
EPS Est.
-$0.14
EPS Surpr.
-42.9%
Revenue
$0.05B
Q1 FY2026
Mar 9, 2026Miss
EPS Actual
-$0.04
EPS Est.
-$0.01
EPS Surpr.
-300.0%
Revenue
$0.05B
Q4 FY2025
Nov 17, 2025Miss
EPS Actual
-$0.10
EPS Est.
-$0.06
EPS Surpr.
-66.7%
Revenue
$0.06B
Q3 FY2025
Aug 4, 2025Miss
EPS Actual
-$0.05
EPS Est.
$0.18
EPS Surpr.
-126.0%
Revenue
$0.06B
Q2 FY2025
May 6, 2025Beat
EPS Actual
$0.01
EPS Est.
-$0.04
EPS Surpr.
+125.0%
Revenue
$0.07B
Q1 FY2025
Mar 10, 2025Beat
EPS Actual
-$0.02
EPS Est.
-$0.04
EPS Surpr.
+50.0%
Revenue
$0.06B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.14
EPS Est.
-$0.12
EPS Surpr.
-16.7%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.13 | $0.13 | $0.13 | 1 |
| Q3 FY2028 | $0.11 | $0.11 | $0.11 | 1 |
| Q2 FY2028 | $0.05 | $0.05 | $0.05 | 1 |
| Q1 FY2028 | $0.05 | $0.05 | $0.05 | 1 |
| Q4 FY2027 | $0.09 | $0.10 | $0.10 | 1 |
| Q3 FY2027 | $0.05 | $0.05 | $0.05 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -42.9% | $5.13 | $5.27 | +2.73% |
| ▼ Q1 FY2026 | Mar 9, 2026 | -300.0% | $3.00 | $3.12 | +4.00% |
| ▼ Q4 FY2025 | Nov 17, 2025 | -66.7% | $4.63 | $4.73 | +2.16% |
| ▼ Q3 FY2025 | Aug 4, 2025 | -126.0% | $9.94 | $12.35 | +24.25% |
| ▲ Q2 FY2025 | May 6, 2025 | +125.0% | $7.54 | $7.76 | +2.92% |
| ▲ Q1 FY2025 | Mar 10, 2025 | +50.0% | $4.67 | $4.27 | -8.57% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -16.7% | $5.06 | $5.13 | +1.38% |
| ▼ Q3 FY2024 | Aug 7, 2024 | -58.3% | $5.79 | $5.37 | -7.25% |
Q2 FY2026+2.73%
Report Date
May 6, 2026
EPS Beat/Miss
-42.9%
Price Before
$5.13
Price After
$5.27
Q1 FY2026+4.00%
Report Date
Mar 9, 2026
EPS Beat/Miss
-300.0%
Price Before
$3.00
Price After
$3.12
Q4 FY2025+2.16%
Report Date
Nov 17, 2025
EPS Beat/Miss
-66.7%
Price Before
$4.63
Price After
$4.73
Q3 FY2025+24.25%
Report Date
Aug 4, 2025
EPS Beat/Miss
-126.0%
Price Before
$9.94
Price After
$12.35
Q2 FY2025+2.92%
Report Date
May 6, 2025
EPS Beat/Miss
+125.0%
Price Before
$7.54
Price After
$7.76
Q1 FY2025-8.57%
Report Date
Mar 10, 2025
EPS Beat/Miss
+50.0%
Price Before
$4.67
Price After
$4.27
Q4 FY2024+1.38%
Report Date
Nov 7, 2024
EPS Beat/Miss
-16.7%
Price Before
$5.06
Price After
$5.13
Q3 FY2024-7.25%
Report Date
Aug 7, 2024
EPS Beat/Miss
-58.3%
Price Before
$5.79
Price After
$5.37
Avg Beat Reaction-2.83%
Avg Miss Reaction+4.55%
Beat Rate2 / 8 quarters
Largest Move+24.25% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: LFMD ends December
LifeMD, Inc. (LFMD) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $-0.20 — missing the analyst consensus of $-0.14 by -42.9%. The next LFMD earnings date is expected around September 1, 2026.
Each quarter, investors track LFMD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LFMD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LFMD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
LFMD earnings · 5 questionsLifeMD, Inc.'s next earnings report is expected around September 1, 2026. LFMD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LFMD historically reports after market close (AMC).
LFMD earnings datewhen is LFMD earningsLFMD next earnings datewhen does LFMD report earningsLFMD earnings calendar
▸ Source: FMP · LifeMD, Inc. SEC filings · US GAAP · LifeMD, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026